A study comparing the effectiveness of pomegranate versus Gabapentin for treatment of Diabetic nephropathy in patients of diabetus melitus type

Phase 2

• Conditions: Type 2 diabetes.; Diabetes mellitus due to underlying condition

• Registration Number: IRCT20141209020258N137
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

Patients with type 2 diabetes who have painful lower extremity nephropathy for at least 3 months
Age between 70 and 30 years
Do not take pomegranate pills.
Do not have severe physical, neurological or psychiatric illness.
Do not become pregnant or breast-feeding.

Exclusion Criteria

Severe sensitivity to pomegranate pills
Severe grade 4 heart failure or unstable angina
HbA1c greater than or equal to 8.5

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ower extremity nephropathy. Timepoint: Start and 3 months after intervention. Method of measurement: Examination.